Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
The Global Alliance for TB Drug Development, Inc. is active in the Medical Devices & Mechanical Engineering technology area. The portfolio currently includes 1 pending office action. This indicates a specific focus on securing intellectual property for their medical technologies.
The examination process is centralized, involving 1 distinct examiner and 1 distinct art unit. This suggests that the technical scope of the filings fits within a single classification. Such a structure simplifies the management of examiner communications and procedural requirements.
SMALE, AVERY E is the busiest examiner, with 1 busiest examiner pending office action currently assigned. This examiner handles the entirety of the company's active prosecution workload. The outcome of the current patent application depends on the specific feedback and decisions of this one examiner.
The direct relationship with 1 distinct examiner simplifies the communication strategy for the applicant. Because the company is managing 1 pending office action, legal efforts can be highly focused. This structure avoids the complexities associated with navigating multiple distinct art units.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SMALE, AVERY E | 1 | 74.2% | +21.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18023401 | METHODS OF PREPARING MODIFIED DOSAGE FORMS AND RELATED COMPONENTS | SMALE, AVERY E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18023401 | METHODS OF PREPARING MODIFIED DOSAGE FORMS AND RELATED COMPONENTS | SMALE, AVERY E | — |
| Art Unit | Apps |
|---|---|
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18023401 | METHODS OF PREPARING MODIFIED DOSAGE FORMS AND RELATED COMPONENTS | SMALE, AVERY E | 3783 | §103§112 | Non-Final OA | — | Pending | Feb 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial